Corrigendum to: Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression (Expert Opinion on Therapeutic Targets, (2014), 18, 10, (1109-1120), 10.1517/14728222.2014.947962);Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 10, 2014, Pages 1109-1120

  Lin, Chiao Wen ^a,b   Chou, Ying Erh ^a   Chiou, Hui Ling ^a   Chen, Mu Kuan ^a,c   Yang, Wei En ^a   Hsieh, Ming Ju ^a,c   Yang, Shun Fa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Migration; MMP 2; Oral cancer; Pterostilbene; Urokinase type plasminogen activator

Indexed keywords

ANTIMETASTATIC AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; STILBENE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE; PTEROSTILBENE;

ARTICLE; CELL INVASION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; MOUTH SQUAMOUS CELL CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; CARCINOMA, SQUAMOUS CELL; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; RNA, MESSENGER; STILBENES; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84907060605     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1080/14728222.2017.1310437     Document Type: Erratum

References (44)

1. Spiro RH, Alfonso AE, Farr HW, et al. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg 1974;128:562-7
2. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-92
3. Yoon SO, Park SJ, Yun CH, et al. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003;36:128-37
4. Chien MH, Lin CW, Cheng CW, et al. Matrix metalloproteinase-2 as a target for head and neck cancer therapy. Expert Opin Ther Targets 2013;17:203-16
5. Yeh CB, Hsieh MJ, Hsieh YH, et al. Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity. PLoS One 2012;7:e31055
6. Yang SF, Chen MK, Hsieh YS, et al. Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food Chem Toxicol 2010;48:1052-8
7. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003;22:395-403
8. Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle 2008;7:2991-6
9. Chien MH, Ying TH, Hsieh YS, et al. Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity. Food Chem Toxicol 2012;50:558-66
10. Peng CY, Yang HW, Chu YH, et al. Caffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway. Evid Based Complement Alternat Med 2012;2012:732578
11. Lin CW, Chen PN, Chen MK, et al. Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS One 2013;8:e80883
12. Ravindranath MH, Ramasamy V, Moon S, et al. Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). Evid Based Complement Alternat Med 2009;6:523-30
13. Shankar S, Ganapathy S, Hingorani SR, et al. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 2008;13:440-52
14. Rimando AM, Cuendet M, Desmarchelier C, et al. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 2002;50:3453-7.
15. Stivala LA, Savio M, Carafoli F, et al. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 2001;276:22586-94
16. Pan MH, Chang YH, Badmaev V, et al. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J Agric Food Chem 2007;55:7777-85
17. McCormack D, McFadden D. Pterostilbene and cancer: Current review. J Surg Res 2012;173:e53-61
18. Ko HS, Kim JS, Cho SM, et al. Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells. Bioorg Med Chem Lett 2014;24:1176-9
19. Lee CM, Su YH, Huynh TT, et al. BlueBerry Isolate, Pterostilbene, Functions as a Potential Anticancer Stem Cell Agent in Suppressing Irradiation-Mediated Enrichment of Hepatoma Stem Cells. Evid Based Complement Alternat Med 2013;2013:258425
20. Huang CS, Ho CT, Tu SH, et al. Long-term ethanol exposure-induced hepatocellular carcinoma cell migration and invasion through lysyl oxidase activation are attenuated by combined treatment with pterostilbene and curcumin analogues. J Agric Food Chem 2013;61:4326-35
21. Hong BH, Wu CH, Yeh CT, et al. Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion. Mol Nutr Food Res 2013;57:886-95
22. Liu Y, Wang L, Wu Y, et al. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. Toxicology 2013;304:120-31
23. Pan MH, Chiou YS, Chen WJ, et al. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 2009;30:1234-42
24. Yeh CB, Hsieh MJ, Lin CW, et al. The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation. PLoS One 2013;8:e56661 25.
25. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211
26. Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China. Phytother Res 2003;17:1127-34
27. Li X, Wang H. Chinese herbal medicine in the treatment of chronic kidney disease. Adv Chronic Kidney Dis 2005;12:276-81
28. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904
29. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis, an imbalance of positive and negative regulation. Cancer Res 1991;51:5054s-9s.
30. Guruvayoorappan C, Kuttan G. Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 2008;30:711-27
31. Okada N, Ishida H, Murata N, et al. Matrix metalloproteinase-2 and-9 in bile as a marker of liver metastasis in colorectal cancer. Biochem Biophys Res Commun 2001;288:212-16
32. Waas ET, Wobbes T, Lomme RM, et al. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 2003;90:1556-64
33. Hwang ES, Lee HJ. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells. Food Chem Toxicol 2008;46:2358-64
34. Zhang L, Shi J, Feng J, et al. Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer. Prostate Cancer Prostatic Dis 2004;7:327-32
35. Benbow U, Brinckerhoff CE. The AP-1 site and MMP gene regulation, what is all the fuss about? Matrix Biol 1997;15:519-26
36. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix, biological consequences. Curr Opin Cell Biol 1998;10:602-8
37. Vincenti MP, White LA, Schroen DJ, et al. Regulating expression of the gene formatrix metalloproteinase-1 (collagenase), mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996;6:391-411
38. Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1990;274:29130-7 .
39. Aggarwal BB. Nuclear factor-kappaB, the enemy within. Cancer Cell 2004;6:203-8
40. Eferl R, Wagner EF. AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 2003;3:859-68
41. Hsieh YS, Chu SC, Yang SF, et al. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis 2007;28:977-87
42. Chen PN, Hsieh YS, Chiang CL, et al. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 2006;85:220-5
43. Meijering E, Dzyubachyk O, Smal I. Methods for cell and particle tracking. Methods Enzymol 2012;504:183-200
44. Kwak YH, Hong SM, Park SS. A single cell tracking system in real-time. Cell Immunol 2010;265:44-9